Fig. 4From: The characteristics of androgen receptor splice variant 7 in the treatment of hormonal sensitive prostate cancer: a systematic review and meta-analysisForest plots of hazard ratios (HRs) for OS of first-line in HSPC patients with different AR-V7 status. Pooled HRs was calculated using fixed effect. The bars indicate 95% CIs. ADT androgen deprivation therapy, AR-V7 androgen receptor splicing variant 7, CI confidence interval, OS overall survivalBack to article page